title: Biosimilar versions of anti-TNF drugs could save NHS money, drug company claims.
authors.affiliation: London.
authors.forename: Nigel
authors.initials: N
authors.lastname: Hawkes
mesh_terms: D059451:Biosimilar Pharmaceuticals / Q000191:economics*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic / Q000191:economics; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D006113:United Kingdom
chemical_list: D059451:Biosimilar Pharmaceuticals; D016568:Drugs, Generic; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha